Navidence Appoints Michael Buck as Chief Solutions Officer.
March 10, 2026 - Navidence, an AI-native healthcare technology company that develops Computable Operational Definitions (CODefs) for the life sciences industry, today announced the promotion of Michael Buck to Chief Solutions Officer (CSO). Buck, who previously served as Senior Vice President of Knowledge Engineering, assumes the newly created role effective immediately.
“Michael has been instrumental in building the knowledge engineering foundation that powers our platform,” said Aaron Kamauu, CEO of Navidence. “As we scale our enterprise partnerships and deepen our impact across the life sciences value chain, this new role positions Michael to lead the full arc of our client solutions—from code lists to definition to delivery. His unique combination of medical informatics domain expertise and vision makes him the ideal leader for this next chapter.”
As Chief Solutions Officer, Buck will oversee the strategic design, delivery, and evolution of Navidence’s client-facing solutions, ensuring that the company’s CODef technology translates into measurable value for life sciences partners. In this expanded role, he will lead knowledge engineering, solution architecture, and client implementation—bridging the gap between Navidence’s AI-driven platform and the complex real-world data needs of pharmaceutical and biotechnology organizations.
Buck will drive cross-functional alignment between product development, data science, and commercial teams to ensure that Navidence’s computable operational definitions meet the rigorous standards required for regulatory-grade research and evidence generation. He will also lead efforts to scale the company’s solutions delivery capabilities as Navidence expands its enterprise client base and deepens engagements across the product lifecycle—from feasibility and protocol design through post-market evidence generation.
“Navidence is at the forefront of transforming how life sciences companies leverage real-world data for clinical research decision-making,” said Buck. “I’m excited to take on this expanded role and work even more closely with our clients and partners to deliver solutions that accelerate research and improve patient outcomes. The opportunity to shape the future of computable evidence at this scale is extraordinary.”
The promotion comes at a pivotal moment for Navidence, which recently announced its Series Seed (preferred) funding round and continues to expand its roster of enterprise clients in the pharmaceutical and biotechnology sectors. The creation of the Chief Solutions Officer role underscores the company’s commitment to delivering end-to-end value for clients navigating an increasingly complex real-world evidence landscape.
About Navidence
Navidence is a technology company that helps healthcare and life science organizations design and assess the use of Real-World Data (RWD) in clinical research studies and clinical trials. Through its platform and Computable Operational Definitions (CODefs), Navidence enables consistent, transparent, and reproducible analysis of complex real-world data to support smarter research and better patient outcomes.
For more information, visit www.navidence.com.